354 related articles for article (PubMed ID: 10815690)
21. Nonsmoking-related arylamine exposure and bladder cancer risk.
Skipper PL; Tannenbaum SR; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
[TBL] [Abstract][Full Text] [Related]
23. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.
Stern MC; Umbach DM; van Gils CH; Lunn RM; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):125-31. PubMed ID: 11219769
[TBL] [Abstract][Full Text] [Related]
24. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk.
Millikan RC; Pittman GS; Newman B; Tse CK; Selmin O; Rockhill B; Savitz D; Moorman PG; Bell DA
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):371-8. PubMed ID: 9610785
[TBL] [Abstract][Full Text] [Related]
25. White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study.
Peluso M; Airoldi L; Armelle M; Martone T; Coda R; Malaveille C; Giacomelli G; Terrone C; Casetta G; Vineis P
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):341-6. PubMed ID: 9568791
[TBL] [Abstract][Full Text] [Related]
26. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer.
Hunter DJ; Hankinson SE; Hough H; Gertig DM; Garcia-Closas M; Spiegelman D; Manson JE; Colditz GA; Willett WC; Speizer FE; Kelsey K
Carcinogenesis; 1997 Nov; 18(11):2127-32. PubMed ID: 9395212
[TBL] [Abstract][Full Text] [Related]
27. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens.
Vineis P; Bartsch H; Caporaso N; Harrington AM; Kadlubar FF; Landi MT; Malaveille C; Shields PG; Skipper P; Talaska G
Nature; 1994 May; 369(6476):154-6. PubMed ID: 7909916
[TBL] [Abstract][Full Text] [Related]
28. Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis.
Terry PD; Goodman M
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):602-11. PubMed ID: 16614098
[TBL] [Abstract][Full Text] [Related]
29. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population.
Marcus PM; Vineis P; Rothman N
Pharmacogenetics; 2000 Mar; 10(2):115-22. PubMed ID: 10761999
[TBL] [Abstract][Full Text] [Related]
30. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma.
Ladero JM; Agúndez JA; Olivera M; Lozano L; Rodríguez-Lescure A; Diaz-Rubio M; Benítez J
Eur J Clin Pharmacol; 2002 May; 58(2):115-8. PubMed ID: 12012143
[TBL] [Abstract][Full Text] [Related]
31. Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review.
Kellen E; Hemelt M; Broberg K; Golka K; Kristensen VN; Hung RJ; Matullo G; Mittal RD; Porru S; Povey A; Schulz WA; Shen J; Buntinx F; Zeegers MP; Taioli E
Am J Epidemiol; 2007 Jun; 165(11):1221-30. PubMed ID: 17404387
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
33. Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk.
Roots I; Drakoulis N; Ploch M; Heinemeyer G; Loddenkemper R; Minks T; Nitz M; Otte F; Koch M
Klin Wochenschr; 1988; 66 Suppl 11():87-97. PubMed ID: 2846954
[TBL] [Abstract][Full Text] [Related]
34. N-acetyltransferase activity--a susceptibility factor in human bladder carcinogenesis.
Dewan A; Chattopadhyay P; Kulkarni PK
Indian J Cancer; 1995 Mar; 32(1):15-9. PubMed ID: 7558106
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of the relationship between slow acetylation of N-acetyl transferase 2 and the risk of bladder cancer.
An Y; Li H; Wang KJ; Liu XH; Qiu MX; Liao Y; Huang JL; Wang XS
Genet Mol Res; 2015 Dec; 14(4):16896-904. PubMed ID: 26681036
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of 20 case-control studies on the N-acetyltransferase 2 acetylation status and colorectal cancer risk.
Ye Z; Parry JM
Med Sci Monit; 2002 Aug; 8(8):CR558-65. PubMed ID: 12165742
[TBL] [Abstract][Full Text] [Related]
37. Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye.
Nohynek GJ; Skare JA; Meuling WJ; Hein DW; De Bie AT; Toutain H
Food Chem Toxicol; 2004 Nov; 42(11):1885-91. PubMed ID: 15350687
[TBL] [Abstract][Full Text] [Related]
38. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine.
Carreón T; Ruder AM; Schulte PA; Hayes RB; Rothman N; Waters M; Grant DJ; Boissy R; Bell DA; Kadlubar FF; Hemstreet GP; Yin S; LeMasters GK
Int J Cancer; 2006 Jan; 118(1):161-8. PubMed ID: 16003747
[TBL] [Abstract][Full Text] [Related]
39. A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer.
Ochs-Balcom HM; Wiesner G; Elston RC
Am J Epidemiol; 2007 Aug; 166(3):246-54. PubMed ID: 17535831
[TBL] [Abstract][Full Text] [Related]
40. Interaction effect in bladder cancer between N-acetyltransferase 2 genotype and alcohol drinking.
Lu CM; Chung MC; Huang CH; Ko YC
Urol Int; 2005; 75(4):360-4. PubMed ID: 16327307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
